| Ticker | PGEN |
|---|---|
| ISIN | US74017N1054 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; m...
El precio actual de Precigen, Inc. (PGEN) es de 4,13 , con una variación del 4,29%.
Precigen, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones